Blank check company Lakeshore Acquisition II Corp. (the "Company"), led by Chairman and CEO Bill Chen, priced its initial public offering of 6,000,000 units at an offering price of $10.00 per unit.
Amazon announced on Wednesday that its board had approved a 20-for-1 stock split and authorized a $10 billion buyback of the internet retailers' shares,...
the Platform to conduct research on critical topics, introduce the results of relevant research into the Company's tumor clinical treatment system, and improve the development of Shineco's digital tumor diagnosis and treatment.
Both Shineco and JSY are poised to seize these opportunities to increase market share in the innovative drug and medical device industry by relying on their business advantages and their synergy cooperation.
Both parties will produce 100 PET tumor precision imaging inspection devices within 2022, and it is expected to achieve sales revenue of RMB750 million (approximately $118 million).
Professor Sun will lead the research and innovation of the company’s tumor treatment and provide technical consultation in early tumor screening and tumor radiotherapy to support the commercialization of digital tumor diagnosis and treatment.
technological development, market evolution, and the COVID-19 pandemic, digital medical and healthcare management industries are ushering in significant development opportunities.
On Tuesday, Yoshitsu Co., Ltd, a Japanese beauty and health products retailer and wholesaler, debuted on the Nasdaq Stock Exchange under the ticker symbol “TKLF”, raising $25 million in its initial public offering (IPO).
